FDA Inspection 1115743 — Aizant Drug Research Solutions Private Ltd.

Aizant Drug Research Solutions Private Ltd. — FEI 3008243902

The FDA completed an inspection of Aizant Drug Research Solutions Private Ltd. on Jan 24, 2020 in Hyderabad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 24, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hyderabad (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.